Treatment of late-onset agoraphobia secondary to depression.
Flint
A J
AJ
D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000223:Adaptation, Psychological / Q000187:drug effects; D000368:Aged; D000369:Aged, 80 and over; D000379:Agoraphobia / Q000188:drug therapy* / Q000523:psychology; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009661:Nortriptyline / Q000627:therapeutic use; D020280:Sertraline; D012803:Sick Role
D000928:Antidepressive Agents; D015057:1-Naphthylamine; D009661:Nortriptyline; D020280:Sertraline